共 50 条
- [42] Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (vol 397, pg 2070, 2021) LANCET, 2021, 397 (10289): : 2048 - 2048
- [45] Prognostic value of modified National Institute of Health activity and chronicity scoring in determining complete renal response in newly diagnosed lupus nephritis: a retrospective single centre study International Urology and Nephrology, 2022, 54 : 2075 - 2082
- [46] CXCR3 Mediates Renal Th1 and Th17 Immune Response in Murine Lupus Nephritis JOURNAL OF IMMUNOLOGY, 2009, 183 (07): : 4693 - 4704
- [48] Assessment of the Potential Impact of Mycophenolate Mofetil on Lowering Renal Biomarkers in Patients with Class III Lupus Nephritis: A Pilot Study to Predict Renal Function Progress BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2024, 8 (03): : 369 - 374
- [50] Initial Preserved Renal Function as a Predictor of Favorable Renal Response to Rituximab in Refractory or Relapsing Lupus Nephritis: A Single-center Cohort Study in Korea JOURNAL OF RHEUMATIC DISEASES, 2022, 29 (01): : 22 - 32